Skip to main content
Editas Medicine, Inc. logo

Editas Medicine, Inc. — Investor Relations & Filings

Ticker · EDIT ISIN · US28106W1036 LEI · 5299000AON4Q9NT2JE42 US Professional, scientific and technical activities
Filings indexed 679 across all filing types
Latest filing 2020-12-18 Board/Management Inform…
Country US United States of America
Listing US EDIT

About Editas Medicine, Inc.

https://www.editasmedicine.com/

Editas Medicine, Inc. is a clinical-stage genome editing company focused on developing transformative medicines for serious diseases using CRISPR technology. The company's mission is to discover, develop, and commercialize durable, precision genomic therapies that can correct the underlying genetic causes of various conditions. Its proprietary platform enables the precise revision, removal, or replacement of DNA. Editas Medicine's research and development pipeline is concentrated on creating both in vivo (in-body) and ex vivo (out-of-body) gene-edited medicines to treat a broad class of diseases, with a focus on rare genetic disorders.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated December 17, 2020, reporting the appointment of a new director to the Board of Directors of Editas Medicine, Inc. It details the increase in board size, the new director's background, committee appointments, and compensation. The key section is Item 5.02, which specifically addresses changes in directors or officers. There is no financial data or report attached, and the content focuses solely on management/board changes. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 5475 characters, sufficient to contain substantive information about the board change rather than a brief announcement or certification.
2020-12-18 English
FORM 4 -
Director's Dealing
2020-12-18 English
FORM 4 -
Director's Dealing
2020-12-11 English
FORM 4 -
Director's Dealing
2020-12-08 English
FORM 4 -
Director's Dealing
2020-11-10 English
FORM 3 -
Director's Dealing
2020-11-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.